{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:01:01Z","timestamp":1777532461485,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijid.2013.04.011","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T15:30:28Z","timestamp":1372692628000},"page":"e902-e906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe"],"prefix":"10.1016","volume":"17","author":[{"given":"Bradley C.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret Z.","family":"Borok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tafadzwa O.","family":"Mhlanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azure T.","family":"Makadzange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.04.011_bib0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ctrv.2006.06.001","article-title":"Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives","volume":"32","author":"Vanni","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijid.2013.04.011_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(02)00263-3","article-title":"Update on Kaposi's sarcoma and other HHV-8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy","volume":"2","author":"Hengge","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2013.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0959-8049(01)00120-4","article-title":"Epidemiology of AIDS-related tumours in developed and developing countries","volume":"37","author":"Dal Maso","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijid.2013.04.011_bib0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00001622-200409000-00010","article-title":"AIDS-associated cancer in developing nations","volume":"16","author":"Orem","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijid.2013.04.011_bib0025","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00002030-200210180-00013","article-title":"Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya","volume":"16","author":"Baeten","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0030","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/00002030-200212060-00014","article-title":"Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria","volume":"16","author":"Eltom","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/367703","article-title":"Human herpesvirus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya","volume":"187","author":"Lavreys","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2013.04.011_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.20242","article-title":"Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia","volume":"75","author":"Klaskala","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2013.04.011_bib0045","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199814000-00024","article-title":"Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985","volume":"12","author":"Olsen","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.10817","article-title":"The seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8) in adults with cancer in Uganda","volume":"103","author":"Newton","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2013.04.011_bib0055","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0060","first-page":"779","article-title":"Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy","volume":"27","author":"Cattelan","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijid.2013.04.011_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/oxfordjournals.jncimonographs.a024256","article-title":"Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"28","author":"Cattelan","year":"2000","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijid.2013.04.011_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00042560-200206010-00015","article-title":"Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone","volume":"30","author":"Paparizos","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2013.04.011_bib0075","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":"The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0080","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0085","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1097\/QAD.0b013e32801086b0","article-title":"Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi","volume":"20","author":"Zachariah","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/605500","article-title":"Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort","volume":"49","author":"Castelnuovo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.04.011_bib0095","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/654800","article-title":"Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe","volume":"51","author":"Borok","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.04.011_bib0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/td.2007.060023","article-title":"Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi","volume":"38","author":"Makombe","year":"2008","journal-title":"Trop Doct"},{"key":"10.1016\/j.ijid.2013.04.011_bib0105","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","article-title":"AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group on AIDS and Tumors and the Italian Cohort of Patients Na\u00efve from Antiretrovirals","volume":"21","author":"Nasti","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijid.2013.04.011_bib0110","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijid.2013.04.011_bib0115","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/00002030-199912240-00012","article-title":"AIDS and cancer in Africa: the evolving epidemic in Zimbabwe","volume":"13","author":"Chokunonga","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.04.011_bib0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ijc.20471","article-title":"Cancer survival in a southern African urban population","volume":"112","author":"Gondos","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2013.04.011_bib0125","doi-asserted-by":"crossref","first-page":"e5790","DOI":"10.1371\/journal.pone.0005790","article-title":"Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis","volume":"4","author":"Brinkhof","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2013.04.011_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0b013e3181a44ef2","article-title":"Loss to care and death before antiretroviral therapy in Durban, South Africa","volume":"51","author":"Bassett","year":"2009","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971213001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T18:18:58Z","timestamp":1563301138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971213001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1201971213001793"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.04.011","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}